Related Experiment Video
Updated: Mar 23, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Streptococcus pyogenes Pneumonia in Adults: Clinical Presentation and Molecular Characterization of Isolates
Esther Tamayo1, Milagrosa Montes1,2, Diego Vicente1,2
1Biomedical Research Center Network for Respiratory Diseases (CIBERES), San Sebastián, Spain.
Introduction:
In the preantibiotic era Streptococcus pyogenes was a common cause of severe pneumonia but currently, except for postinfluenza complications, it is not considered a common cause of community-acquired pneumonia in adults.
Aim And Material And Methods:
This study aimed to identify current clinical episodes of S. pyogenes pneumonia, its relationship with influenza virus circulation and the genotypes of the involved isolates during a decade in a Southern European region (Gipuzkoa, northern Spain). Molecular analysis of isolates included emm, multilocus-sequence typing, and superantigen profile determination.
Results:
Forty episodes were detected (annual incidence 1.1 x 100,000 inhabitants, range 0.29-2.29). Thirty-seven episodes were community-acquired, 21 involved an invasive infection and 10 developed STSS. The associated mortality rate was 20%, with half of the patients dying within 24 hours after admission. Influenza coinfection was confirmed in four patients and suspected in another. The 52.5% of episodes occurred outside the influenza seasonal epidemic. The 67.5% of affected persons were elderly individuals and adults with severe comorbidities, although 13 patients had no comorbidities, 2 of them had a fatal outcome. Eleven clones were identified, the most prevalent being emm1/ST28 (43.6%) causing the most severe cases.
Conclusions:
S. pyogenes pneumonia had a continuous presence frequently unrelated to influenza infection, being rapidly fatal even in previously healthy individuals.
Insights
Streptococcus pyogenes pneumonia remains a serious threat, often occurring independently of influenza. This bacterial pneumonia can be rapidly fatal, even in healthy individuals, highlighting its persistent danger.
Area of Science:
- Infectious Diseases
- Bacteriology
- Epidemiology
Background:
- Streptococcus pyogenes was historically a major cause of pneumonia before antibiotics.
- Currently, it's not widely recognized as a common cause of adult community-acquired pneumonia, except in post-influenza cases.
Purpose of the Study:
- To investigate contemporary Streptococcus pyogenes pneumonia cases.
- To determine the link between S. pyogenes pneumonia and influenza virus circulation.
- To analyze the genetic profiles of S. pyogenes isolates over a decade in Northern Spain.
Main Methods:
- Molecular analysis of S. pyogenes isolates.
- Included emm typing, multilocus-sequence typing (MLST), and superantigen profiling.
- Retrospective decade-long study in Gipuzkoa, Spain.
Main Results:
- Forty episodes of S. pyogenes pneumonia were identified (incidence 1.1/100,000 annually).
- Most cases were community-acquired (37/40), with 21 invasive infections and 10 developing streptococcal toxic shock syndrome (STSS).
- Mortality was high (20%), with a significant proportion of cases occurring outside influenza season and affecting elderly/comorbid individuals, but also previously healthy ones.
Conclusions:
- S. pyogenes pneumonia persists as a significant clinical threat.
- The infection is often unrelated to concurrent influenza activity.
- The condition can be rapidly fatal, irrespective of patient comorbidities.
More Related Videos
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Atypical Pneumonia
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment